Anatolii G. Kochetov

Anatolii G. Kochetov

Auto-generated profile, based on publicly available information

Anatolii G. Kochetov

The Russian National Research Medical University named after N.I. Pirogov

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2002 in Bulletin of Experimental Biology and Medicine
Verified
Journal Article
Closed access
PDF file
NIN. L. Irodova
N. L. Irodova
VLV. Z. Lankin
V. Z. Lankin
GKG. K. Konovalova
G. K. Konovalova
AKA. G. Kochetov
A. G. Kochetov
ICI. E. Chazova
I. E. Chazova

1 January 2015 in S.S. Korsakov Journal of Neurology and Psychiatry
Verified
Journal Article
Closed access
EKE. V. Konstantinova
E. V. Konstantinova
AKA. G. Kochetov
A. G. Kochetov
NSN. A. Shostak
N. A. Shostak
MSM. Kh. Shurdumova
M. Kh. Shurdumova
IEIlya Eremin
Ilya Eremin
VSV. I. Skvortsova
V. I. Skvortsova
Издательство Медиа Сфера - 25 медицинских журналов общим тиражом около 500 000 экземпляров в год, представлены в международных базах данных Scopus, Medline, и Google Scolar, включены в перечень изданий ВАК, представлены в РИНЦ

30 March 2021 in Russian Clinical Laboratory Diagnostics
Verified
Journal Article
Open access
OIO. O. Ivoylov
O. O. Ivoylov
AKA. G. Kochetov
A. G. Kochetov
The basis for calculating the cost price of any product, including laboratory tests, is based on an estimate of direct costs of the production. At present, there are no systematic ideas about the structure of such costs, and approaches to their analysis have not been defined, in the management practice of medical laboratories. The purpose of this work was developing and testing a method for analyzing the structure of direct costs and their allocation bases when calculating the cost of a laboratory test. We analyzed data on the volume of laboratory tests performed in the clinical diagnostic laboratory of the National Medical Research Center of Cardiology, prices for purchased reagents and consumables, depreciation and maintenance costs of equipment, staff salaries. As a result, we proposed a typical component structure of direct costs, established the allocation bases of fixed costs, and determined the ratio of some variable cost components to onе product unit cost. On the basis of these concepts, an algorithm for calculating the total direct laboratory (technological) cost per test has been developed, which makes it possible to simulate the cost structure under conditions of arbitrarily specified variables. During the testing of the algorithm, the values of direct costs and the technological cost per test were calculated for billable (ordered) laboratory tests. Comparison of the economic efficiency of various methods, as well as modeling of changes in the cost depending on the volume of testing and the turn-around time (TAT) has been performed. It can be concluded that the approach to creating the tables of the technological cost per test based on dividing direct costs into variable and fixed costs and structuring them by components and allocation bases is an effective tool for medical laboratory management.

15 October 2021 in Consilium Medicum
Verified
Journal Article
Open access
PDF file
IZIgor V. Zhirov
Igor V. Zhirov
SNSvetlana N. Nasonova
Svetlana N. Nasonova
UKUlkiar A. Khalilova
Ulkiar A. Khalilova
YOYulia F. Osmolovskaya
Yulia F. Osmolovskaya
OCOlga Ia. Chaikovskaia
Olga Ia. Chaikovskaia
ТНТерещенко Сергей Николаевич
Терещенко Сергей Николаевич
Acute heart failure (HF) is a syndrome requiring urgent treatment. Due to drastic increase in the number of HF patients this problem is still of great importance for modern public health care and has a significant impact on morbidity and mortality. This article presents modern approaches to the classification of this condition, describes diagnostic algorithms, and discovers general methods of acute HF therapy. Two clinical axes are described the presence of stasis in one or two circuits of blood circulation and peripheral hypoperfusion, on the basis of which the individual approaches to treatment strategy of patients with this symptom complex are developed.

26 May 2022 in Terapevticheskii arkhiv
Verified
Journal Article
Open access
PDF file
AKAnatoly G. Kochetov
Anatoly G. Kochetov
OLOlga V. Lyang
Olga V. Lyang
IZIrina A. Zhirova
Irina A. Zhirova
OIOleg O. Ivoylov
Oleg O. Ivoylov
RPRita R. Politidis
Rita R. Politidis
YNYulia V. Novozhenova
Yulia V. Novozhenova
Background. Bacterial pneumonia is a frequent complication of ischemic stroke at the hospital stage. The search for prognostic laboratory markers of pneumonia remains an urgent task, as it will allow to individualize the approach to the treatment and rehabilitation of such patients. Aim. To investigate the prognostic significance of proteins of the acute phase of inflammation, as well as to evaluate them as early predictors of the development of pneumonia in patients with ischemic stroke. Materials and methods. The study included 302 patients in the acute period of ischemic stroke. C-reactive protein (CRP), tumor necrosis factor , interleukin-6 (IL-6), neutrophil elastase, neopterin, serum amyloid A (SAA), secreted phospholipase type 2 (sPLA2) were determined in all patients on the first day by enzyme immunoassay. Statistical data processing was carried out using SPSS and Microsoft Excel software (USA). Results. At the hospital stage, pneumonia developed in 82/302 patients (27.2%; 95% confidence interval 22.332.3%). The levels of CRP, IL-6, sPLA2, SAA and neopterin significantly differed in the presence and absence of pneumonia. Step-by-step logistic regression analysis revealed the significance of IL-6 and CRP concentrations in the prognosis of pneumonia. The threshold value of IL-6 concentration was 3.45 pg/ml (sensitivity 82.4%, specificity 66.7%). The prognostic value of a positive result (PPR) in the prognosis of pneumonia was 40%, a negative result (PNR) 92%. The threshold value of CRP was 1640 mg/l with a sensitivity of 65.8% and a specificity of 74.8%. The PPR of the threshold value of the concentration of CRP was 45%, PNR 80%. Conclusion. The measurement of the concentration of IL-6 and CRP on the first day of ischemic stroke makes it possible to identify patients with the greatest risk of pneumonia at the hospital stage. The results of the work indicate the necessity to include CRP and IL-6 in the list of mandatory laboratory tests that should be carried out for each patient with ischemic stroke on the first day from the onset of the disease.

1 January 2012
Verified
Journal Article
Closed access
OLO V Liang
O V Liang
AKA G Kochetov
A G Kochetov
NSN A Shamalov
N A Shamalov
KAK V Anisimov
K V Anisimov
GRG R Ramazanov
G R Ramazanov
VEV O Egorov
V O Egorov